Sodium‐glucose cotransporter type 2 channel inhibitor: Breakthrough in the treatment of neutropenia in patients with glycogen storage disease type 1b?
2022; Wiley; Volume: 63; Issue: 3 Linguagem: Inglês
10.1002/jmd2.12278
ISSN2192-8312
AutoresMagdalena Kaczor, Milena Greczan, Karolina Kierus, Ewa Ehmke vel Emczyńska‐Seliga, Elżbieta Ciara, Barbara Piątosa, Dariusz Rokicki, Janusz Książyk, Dorota Wesół‐Kucharska,
Tópico(s)Oral and gingival health research
ResumoGlycogen storage disease type 1b (GSD 1b) is an inherited metabolic defect caused by biallelic mutations in the
Referência(s)